Northwestern Mutual Wealth Management
YARW

Northwestern Mutual Wealth Management’s Yarrow Bioscience YARW Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16
Closed -$478 – 4484
2026
Q1 		$478 Hold
16
– – ﹤0.01% 3858
2025
Q4 		$464 Buy
+16
New +$321 ﹤0.01% 3726
2025
Q3 		– Hold
0
– -$18 – 4070
2025
Q2 		– Hold
0
– – – 3617
2023
Q2 		– Sell
-1
Closed -$148 – 3634
2023
Q1 		$148 Hold
1
– – ﹤0.01% 3220
2022
Q4 		$131 Hold
1
– – ﹤0.01% 3214
2022
Q3 		$0 Hold
1
– – ﹤0.01% 3428
2022
Q2 		$0 Hold
1
– – ﹤0.01% 3501
2022
Q1 		$1K Hold
1
– – ﹤0.01% 3042
2021
Q4 		$1K Hold
1
– – ﹤0.01% 3074
2021
Q3 		$1K Buy
+1
New +$1.94K ﹤0.01% 2959

Other funds holding YARW

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Northwestern Mutual Wealth Management's YARW Position: Q2 2026 in Review

Northwestern Mutual Wealth Management sold out of Yarrow Bioscience (YARW) in Q2 2026, closing a stake of 16 shares — an estimated $478 sold.

Northwestern Mutual Wealth Management first reported a position in YARW in Q3 2021 and held it in 9 quarters. The position peaked at $1K in Q1 2022. 40 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

  • Northwestern Mutual Wealth Management reported no remaining Yarrow Bioscience position as of Q2 2026 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 16 Yarrow Bioscience shares in Q2 2026, an estimated $478.
  • Northwestern Mutual Wealth Management first reported a position in Yarrow Bioscience in Q3 2021 and held it in 9 quarters.
  • Northwestern Mutual Wealth Management's Yarrow Bioscience position peaked at $1K in Q1 2022.
  • 40 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.